Related references
Note: Only part of the references are listed.Interleukin-18: Biological properties and role in disease pathogenesis
Gilles Kaplanski
IMMUNOLOGICAL REVIEWS (2018)
Mechanisms of NLRP1-Mediated Autoinflammatory Disease in Humans and Mice
Chien-Hsiung Yu et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Guanghong Jia et al.
DIABETOLOGIA (2018)
Medication use for the treatment of diabetes in obese individuals
John P. H. Wilding
DIABETOLOGIA (2018)
MLKL Activation Triggers NLRP3-Mediated Processing and Release of IL-1β Independently of Gasdermin-D
Kimberley D. Gutierrez et al.
JOURNAL OF IMMUNOLOGY (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
POSTTRANSLATIONAL MODIFICATION AS A CRITICAL DETERMINANT OF CYTOPLASMIC INNATE IMMUNE RECOGNITION
Paul J. Baker et al.
PHYSIOLOGICAL REVIEWS (2017)
Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus
Yao Wang et al.
PLOS ONE (2017)
Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner
Stephanie A. Conos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Interleukin-22 ameliorated renal injury and fibrosis in diabetic nephropathy through inhibition of NLRP3 inflammasome activation
Shaofei Wang et al.
CELL DEATH & DISEASE (2017)
LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy
Hong Yi et al.
CELL DEATH & DISEASE (2017)
Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling
Miaomiao Lu et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Function of NLRP3 in the Pathogenesis and Development of Diabetic Nephropathy
Ying Fu et al.
MEDICAL SCIENCE MONITOR (2017)
NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
Beibei Luo et al.
FRONTIERS IN PHYSIOLOGY (2017)
Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming
Xiuting Liu et al.
ANTIOXIDANTS & REDOX SIGNALING (2017)
The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation
Kalpana Manthiram et al.
NATURE IMMUNOLOGY (2017)
The addition of vildagliptin to metformin prevents the elevation of interleukin 1β in patients with type 2 diabetes and coronary artery disease: a prospective, randomized, open-label study
Arwa Younis et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Are targeted therapies for diabetic cardiomyopathy on the horizon?
Mitchel Tate et al.
CLINICAL SCIENCE (2017)
Opposing effects of Nrf2 and Nrf2-activating compounds on the NLRP3 inflammasome independent of Nrf2-mediated gene expression
Martha Garstkiewicz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
SGLT-2 Inhibition with Dapagliflozin Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Cardiomyopathy in Mice with Type 2 Diabetes. Further Augmentation of the Effects with Saxagliptin, a DPP4 Inhibitor
Yumei Ye et al.
CARDIOVASCULAR DRUGS AND THERAPY (2017)
Exendin-4 attenuates adverse cardiac remodelling in streptozocin-induced diabetes via specific actions on infiltrating macrophages
Mitchel Tate et al.
BASIC RESEARCH IN CARDIOLOGY (2016)
A Genome-wide CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Screen Identifies NEK7 as an Essential Component of NLRP3 Inflammasome Activation
Jonathan L. Schmid-Burgk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Sulforaphane inhibits multiple inflammasomes through an Nrf2-independent mechanism
Allison J. Greaney et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
Hexin Shi et al.
NATURE IMMUNOLOGY (2016)
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Guanghong Jia et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Cell death is not essential for caspase-1-mediated interleukin-1β activation and secretion
S. A. Conos et al.
CELL DEATH AND DIFFERENTIATION (2016)
IL-18 Production from the NLRP1 Inflammasome Prevents Obesity and Metabolic Syndrome
Andrew J. Murphy et al.
CELL METABOLISM (2016)
The intersection of cell death and inflammasome activation
James E. Vince et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Manasi S. Shah et al.
CIRCULATION RESEARCH (2016)
Differential effects of NOX4 and NOX1 on immune cell-mediated inflammation in the aortic sinus of diabetic ApoE-/- mice
Elyse Di Marco et al.
CLINICAL SCIENCE (2016)
GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death
Lorenzo Sborgi et al.
EMBO JOURNAL (2016)
Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs)
Neil A. Turner
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Caspase-1, but Not Caspase-3, Promotes Diabetic Nephropathy
Khurrum Shahzad et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE-/- Mice
Weiling Leng et al.
MEDIATORS OF INFLAMMATION (2016)
Pore-forming activity and structural autoinhibition of the gasdermin family
Jingjin Ding et al.
NATURE (2016)
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
Xing Liu et al.
NATURE (2016)
NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
Yuan He et al.
NATURE (2016)
GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes
Robin A. Aglietti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice
Gustavo Monnerat et al.
NATURE COMMUNICATIONS (2016)
Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription
Eri H. Kobayashi et al.
NATURE COMMUNICATIONS (2016)
β-Hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via AMPK activation
Ha Ram Bae et al.
ONCOTARGET (2016)
NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
Geena Paramel Varghese et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2016)
High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells
Hong Feng et al.
JOURNAL OF DIABETES RESEARCH (2016)
Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathy
Khurrum Shahzad et al.
SCIENTIFIC REPORTS (2016)
Empagliflozin Protects against Diet-Induced NLRP-3 Inflammasome Activation and Lipid Accumulation
Elisa Benetti et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Dipeptidyl peptidase-4 inhibition by Saxagliptin prevents inflammation and renal injury by targeting the Nlrp3/ASC inflammasome
Yochai Birnbaum et al.
BMJ OPEN DIABETES RESEARCH & CARE (2016)
Anti-Inflammatory and Antiatherogenic Effects of the NLRP3 Inflammasome Inhibitor Arglabin in ApoE2.Ki Mice Fed a High-Fat Diet
Amna Abderrazak et al.
CIRCULATION (2015)
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1 via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients
P. Ruscitti et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2015)
The Role of NADPH Oxidase in Vascular Disease - Hypertension, Atherosclerosis & Stroke
Stephen P. Gray et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats
Irene Paterniti et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr-/- mice
Tim Hendrikx et al.
FEBS JOURNAL (2015)
The Importance of NLRP3 Inflammasome in Heart Failure
Brittany Butts et al.
JOURNAL OF CARDIAC FAILURE (2015)
Interleukin-18-induced atherosclerosis involves CD36 and NF-κB crosstalk in Apo E-/- mice
Owais Mohammad Bhat et al.
JOURNAL OF CARDIOLOGY (2015)
Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
Xin Shi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Revisiting inflammation in diabetic nephropathy: the role of the Nlrp3 inflammasome in glomerular resident cells
Norihiko Sakai et al.
KIDNEY INTERNATIONAL (2015)
Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy
Khurrum Shahzad et al.
KIDNEY INTERNATIONAL (2015)
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Nobuhiko Kayagaki et al.
NATURE (2015)
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi et al.
NATURE (2015)
Inflammasomes: mechanism of action, role in disease, and therapeutics
Haitao Guo et al.
NATURE MEDICINE (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
NLRP3 Inflammasome Polymorphism and Macrovascular Complications in Type 2 Diabetes Patients
Jasna Klen et al.
JOURNAL OF DIABETES RESEARCH (2015)
Expression of the NLRP3 Inflammasome in Carotid Atherosclerosis
Xin Shi et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2015)
Localizations of Na+-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
Ivana Vrhovac et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
Ema Ozaki et al.
JOURNAL OF INFLAMMATION RESEARCH (2015)
Inflammasome Activation by Mitochondrial Oxidative Stress in Macrophages Leads to the Development of Angiotensin II-Induced Aortic Aneurysm
Fumitake Usui et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy
Su-Mi Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Sodium/Glucose Cotransporter 2 Inhibitors and Prevention of Diabetic Nephropathy: Targeting the Renal Tubule in Diabetes
Luca De Nicola et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Ambiguities in NLRP3 inflammasome regulation: Is there a role for mitochondria?
Kate E. Lawlor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice
Jian Cai et al.
CARDIOVASCULAR DIABETOLOGY (2014)
The interleukin-1 receptor antagonist anakinra improves endothelial dysfunction in streptozotocin-induced diabetic rats
Susana Vallejo et al.
CARDIOVASCULAR DIABETOLOGY (2014)
The NLRP3 Inflammasome and Diabetic Cardiomyopathy
Lalit P. Singh
CARDIOVASCULAR DRUGS AND THERAPY (2014)
Rosuvastatin Alleviates Diabetic Cardiomyopathy by Inhibiting NLRP3 Inflammasome and MAPK Pathways in a Type 2 Diabetes Rat Model
Beibei Luo et al.
CARDIOVASCULAR DRUGS AND THERAPY (2014)
Prion-like Polymerization Underlies Signal Transduction in Antiviral Immune Defense and Inflammasome Activation
Xin Cai et al.
CELL (2014)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes
Nathalie Esser et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Nuclear Factor E2-related Factor-2 (Nrf2) Is Required for NLRP3 and AIM2 Inflammasome Activation
Changcheng Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Mitochondrial NLRP3 Protein Induces Reactive Oxygen Species to Promote Smad Protein Signaling and Fibrosis Independent from the Inflammasome
Nathan A. Bracey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia-Reperfusion in the Mouse
Carlo Marchetti et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
Scott W. Canna et al.
NATURE GENETICS (2014)
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Bernardo S. Franklin et al.
NATURE IMMUNOLOGY (2014)
NLRP3 Gene Silencing Ameliorates Diabetic Cardiomyopathy in a Type 2 Diabetes Rat Model
Beibei Luo et al.
PLOS ONE (2014)
The Neutrophil NLRC4 Inflammasome Selectively Promotes IL-1β Maturation without Pyroptosis during Acute Salmonella Challenge
Kaiwen W. Chen et al.
CELL REPORTS (2014)
Sterol Regulatory Element Binding Protein 2 Activation of NLRP3 Inflammasome in Endothelium Mediates Hemodynamic-Induced Atherosclerosis Susceptibility
Han Xiao et al.
CIRCULATION (2013)
Inflammation and the pathogenesis of diabetic nephropathy
Jun Wada et al.
CLINICAL SCIENCE (2013)
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Hye-Mi Lee et al.
DIABETES (2013)
Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice
Atsuo Tahara et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
Raul Munoz-Planillo et al.
IMMUNITY (2013)
Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease
Stacey Ruiz et al.
KIDNEY INTERNATIONAL (2013)
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2013)
Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?
Usha Panchapakesan et al.
PLOS ONE (2013)
Activation of Sterol Regulatory Element Binding Protein and NLRP3 Inflammasome in Atherosclerotic Lesion Development in Diabetic Pigs
Yu Li et al.
PLOS ONE (2013)
Oxidized Low Density Lipoprotein Induced Caspase-1 Mediated Pyroptotic Cell Death in Macrophages: Implication in Lesion Instability?
Jing Lin et al.
PLOS ONE (2013)
Taking Diabetes to Heart-Deregulation of Myocardial Lipid Metabolism in Diabetic Cardiomyopathy
Marina Bayeva et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Activation and regulation of the inflammasomes
Eicke Latz et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
Jessica Gage et al.
CANADIAN JOURNAL OF CARDIOLOGY (2012)
Cannabinoid 1 Receptor Promotes Cardiac Dysfunction, Oxidative Stress, Inflammation, and Fibrosis in Diabetic Cardiomyopathy
Mohanraj Rajesh et al.
DIABETES (2012)
Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr-/- Mice Compared to Nondiabetic LDLr-/- Mice
Daniel Engelbertsen et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats
W. B. Zhang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
IL-1 and atherosclerosis: a murine twist to an evolving human story
Daniel J. Rader
JOURNAL OF CLINICAL INVESTIGATION (2012)
NF-E2-Related Factor 2 Promotes Atherosclerosis by Effects on Plasma Lipoproteins and Cholesterol Transport That Overshadow Antioxidant Protection
Berenice Barajas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
P. Menu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Glyburide Is Anti-inflammatory and Associated with Reduced Mortality in Melioidosis
Gavin C. K. W. Koh et al.
CLINICAL INFECTIOUS DISEASES (2011)
Understanding the mechanism of IL-1β secretion
Gloria Lopez-Castejon et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2011)
Elimination of the NLRP3-ASC Inflammasome Protects against Chronic Obesity-Induced Pancreatic Damage
Yun-Hee Youm et al.
ENDOCRINOLOGY (2011)
Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis
Stefan Freigang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
Anti-apoptotic potential of rosuvastatin pretreatment in murine model of cardiomyopathy
Himanshu Sharma et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Haitao Wen et al.
NATURE IMMUNOLOGY (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
Inflammasome is a central player in the induction of obesity and insulin resistance
Rinke Stienstra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse
Eleonora Mezzaroma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome
P. Menu et al.
CELL DEATH & DISEASE (2011)
The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
Rinke Stienstra et al.
CELL METABOLISM (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L. Masters et al.
NATURE IMMUNOLOGY (2010)
Myocardial remodeling after infarction: the role of myofibroblasts
Susanne W. M. van den Borne et al.
NATURE REVIEWS CARDIOLOGY (2010)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy
S. Van Linthout et al.
DIABETOLOGIA (2007)
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
V. Petrilli et al.
CELL DEATH AND DIFFERENTIATION (2007)
Interleukin-18, the metabolic syndrome, and subclinical atherosclerosis results from the Dallas heart study
Andreas Zirlik et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency
Eric P. Zorriila et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Inflammation and metabolic disorders
Goekhan S. Hotamisligil
NATURE (2006)
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
MG Netea et al.
NATURE MEDICINE (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans
CP Fischer et al.
CLINICAL IMMUNOLOGY (2005)
ATP-sensitive potassium channelopathies: focus on insulin secretion
FM Ashcroft
JOURNAL OF CLINICAL INVESTIGATION (2005)
Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance
J Hung et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
R Elhage et al.
CARDIOVASCULAR RESEARCH (2003)
Lack of interleukin-1β decreases the severity of atherosclerosis in ApoE-deficient mice
H Kirii et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Stimulation of collagen production by transforming growth factor-β1 during differentiation of cardiac fibroblasts to myofibroblasts
VV Petrov et al.
HYPERTENSION (2002)
Biochemistry and molecular cell biology of diabetic complications
M Brownlee
NATURE (2001)
Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: Implications for management
E Khaleeli et al.
AMERICAN HEART JOURNAL (2001)
Antioxidant vitamins and prevention of cardiovascular disease: Epidemiological and clinical trial data
R Marchioli et al.
LIPIDS (2001)
Share Paper
